STOCK TITAN

Alkermes (ALKS) CCO granted options and RSUs, sells 6,000 shares at $30

Filing Impact
(Moderate)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Alkermes plc senior vice president and chief commercial officer Christian Todd Nichols reported both equity awards and a share sale. He received an employee stock option for 66,430 shares and a restricted stock unit award for 30,854 units, each at a grant price of $0.00 per share. Both the option and RSUs vest in four equal annual installments, starting on 3/2/2027. On the same date, he sold 6,000 ordinary shares at $30.00 per share in an open-market transaction effected under a pre-established Rule 10b5-1 trading plan adopted on 11/19/2025, and held 109,769 ordinary shares afterward.

Positive

  • None.

Negative

  • None.

Insights

Routine equity awards combined with a planned 10b5-1 sale; overall neutral.

The reporting person, a senior commercial executive at Alkermes plc, received sizable equity compensation on 3/2/2026: an option for 66,430 shares and 30,854 restricted stock units, both granted at $0.00. These awards vest in four equal annual installments starting on 3/2/2027, aligning incentives with longer-term company performance.

On the same date, he executed an open-market sale of 6,000 ordinary shares at $30.00 per share, totaling $180,000. A footnote states the sale was made under a Rule 10b5-1 trading plan adopted on 11/19/2025, indicating it was pre-arranged rather than opportunistic. After the sale, he retained 109,769 ordinary shares, alongside the newly granted options and RSUs.

The combination of long-vesting awards and a relatively modest, pre-planned sale suggests standard executive compensation and liquidity management. Future company filings may show how much of these awards ultimately vest and are exercised over the vesting period beginning in 2027.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Nichols Christian Todd

(Last) (First) (Middle)
900 WINTER STREET

(Street)
WALTHAM MA 02451

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Alkermes plc. [ ALKS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
SVP, Chief Commercial Officer
3. Date of Earliest Transaction (Month/Day/Year)
03/02/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Ordinary Shares 03/02/2026 S(1) 6,000 D $30 109,769 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (Right to Buy) $30.25 03/02/2026 A 66,430 (2) 03/02/2036 Ordinary Shares 66,430 $0 66,430 D
Restricted Stock Unit Award (3) 03/02/2026 A 30,854 (4) (4) Ordinary Shares 30,854 $0 30,854 D
Explanation of Responses:
1. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/19/2025.
2. Shares underlying the stock option vest and become exercisable in four equal annual installments, commencing on 3/2/2027.
3. Each restricted stock unit represents a contingent right to receive one ordinary share.
4. Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 3/2/2027.
/s/ Shantale Greenson, attorney-in-fact for Christian Todd Nichols 03/04/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Alkermes (ALKS) SVP Christian Todd Nichols report?

Christian Todd Nichols reported new equity awards and a share sale. He received stock options for 66,430 shares, 30,854 restricted stock units, and sold 6,000 ordinary shares in an open-market transaction, all dated March 2, 2026.

How many Alkermes (ALKS) shares did the insider sell and at what price?

He sold 6,000 Alkermes ordinary shares at $30.00 per share. The transaction was classified as an open-market sale and was executed under a pre-established Rule 10b5-1 trading plan adopted on November 19, 2025.

What stock option and RSU awards did the Alkermes (ALKS) executive receive?

He received an employee stock option covering 66,430 shares and a restricted stock unit award for 30,854 units. Both were granted at a $0.00 exercise or purchase price as part of his equity compensation package.

When do the new Alkermes (ALKS) stock options and RSUs vest for the insider?

The stock options and restricted stock units each vest in four equal annual installments. Vesting for both awards begins on March 2, 2027, spreading the potential share delivery and exercisability over four years.

How many Alkermes (ALKS) shares does Christian Todd Nichols hold after the sale?

Following the March 2, 2026 open-market sale, he directly held 109,769 ordinary shares. This holding is separate from the newly granted stock options and restricted stock units, which vest over future years starting in 2027.

Was the Alkermes (ALKS) insider sale part of a Rule 10b5-1 trading plan?

Yes. A footnote specifies the 6,000-share sale was effected under a Rule 10b5-1 trading plan adopted on November 19, 2025. Such plans pre-schedule trades, helping separate them from short-term market timing decisions.
Alkermes Plc

NASDAQ:ALKS

ALKS Rankings

ALKS Latest News

ALKS Latest SEC Filings

ALKS Stock Data

4.88B
161.36M
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
Ireland
DUBLIN 4